These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 23121365)

  • 21. Association between IL28B gene polymorphisms and plasma HCV-RNA levels in HIV/HCV-co-infected patients.
    Labarga P; Soriano V; Caruz A; Poveda E; Di Lello FA; Hernandez-Quero J; Moreno S; Bernal E; Miró JM; Leal M; Gutierrez F; Portilla J; Pineda JA;
    AIDS; 2011 Mar; 25(6):761-6. PubMed ID: 21378537
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Host and viral determinants of the outcome of exposure to HCV infection genotype 4: a large longitudinal study.
    Kamal SM; Kassim SK; Ahmed AI; Mahmoud S; Bahnasy KA; Hafez TA; Aziz IA; Fathelbab IF; Mansour HM
    Am J Gastroenterol; 2014 Feb; 109(2):199-211. PubMed ID: 24445571
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interleukin-28B rs12979860C/T and rs8099917T/G contribute to spontaneous clearance of hepatitis C virus in Caucasians.
    Zheng MH; Li Y; Xiao DD; Shi KQ; Fan YC; Chen LL; Liu WY; Luo YW; Chen YP
    Gene; 2013 Apr; 518(2):479-82. PubMed ID: 23266640
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potential role for interleukin-28B genotype in treatment decision-making in recent hepatitis C virus infection.
    Grebely J; Petoumenos K; Hellard M; Matthews GV; Suppiah V; Applegate T; Yeung B; Marks P; Rawlinson W; Lloyd AR; Booth D; Kaldor JM; George J; Dore GJ;
    Hepatology; 2010 Oct; 52(4):1216-24. PubMed ID: 20803561
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Apolipoprotein H expression is associated with IL28B genotype and viral clearance in hepatitis C virus infection.
    Laird ME; Mohsen A; Duffy D; Mamdouh R; LeFouler L; Casrouge A; El-Daly M; Rafik M; Abdel-Hamid M; Soulier A; Pawlotsky JM; Hézode C; Rosa I; Renard P; Mohamed MK; Bonnard P; Izopet J; Mallet V; Pol S; Albert ML; Fontanet A
    J Hepatol; 2014 Oct; 61(4):770-6. PubMed ID: 24905490
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polymorphism of the IL28B gene (rs8099917, rs12979860) and virological response of Pakistani hepatitis C virus genotype 3 patients to pegylated interferon therapy.
    Aziz H; Raza A; Ali K; Khattak JZ; Irfan J; Gill ML
    Int J Infect Dis; 2015 Jan; 30():91-7. PubMed ID: 25462177
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic variation in interleukin 28B with respect to vertical transmission of hepatitis C virus and spontaneous clearance in HCV-infected children.
    Ruiz-Extremera A; Muñoz-Gámez JA; Salmerón-Ruiz MA; de Rueda PM; Quiles-Pérez R; Gila-Medina A; Casado J; Belén Martín A; Sanjuan-Nuñez L; Carazo A; Pavón EJ; Ocete-Hita E; León J; Salmerón J
    Hepatology; 2011 Jun; 53(6):1830-8. PubMed ID: 21413051
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of genetic variation in IL28B, IFNL4 and HLA genes on treatment responses against chronic hepatitis C virus infection.
    Sakhaee F; Ghazanfari M; Vaziri F; Jamnani FR; Davari M; Gharibzadeh S; Fateh R; Abdolrahimi F; Dizaji SP; Fateh A; Siadat SD
    Infect Genet Evol; 2017 Oct; 54():330-337. PubMed ID: 28739427
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IL28B polymorphisms predict reduction of HCV RNA from the first day of therapy in chronic hepatitis C.
    Bochud PY; Bibert S; Negro F; Haagmans B; Soulier A; Ferrari C; Missale G; Zeuzem S; Pawlotsky JM; Schalm S; Hellstrand K; Neumann AU; Lagging M
    J Hepatol; 2011 Nov; 55(5):980-8. PubMed ID: 21354446
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation of IL28B rs12979860 genotype and gender with spontaneous clearance of HCV infection: a Pakistani cross-section study.
    Ali Q; Jamal A; Imran M; Ullah S; Kalam I; Ullah S; Waqar AB
    Per Med; 2018 Nov; 15(6):495-502. PubMed ID: 30398404
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased risk of severe hepatitis C virus recurrence after liver transplantation in patients with a T allele of IL28B rs12979860.
    Cisneros E; Baños I; Citores MJ; Duca A; Salas C; Noblejas A; Cañizares M; Millán I; Cuervas-Mons V; Vilches C
    Transplantation; 2012 Aug; 94(3):275-80. PubMed ID: 22790387
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Strong prediction of virological response to combination therapy by IL28B gene variants rs12979860 and rs8099917 in chronic hepatitis C genotype 4.
    Ragheb MM; Nemr NA; Kishk RM; Mandour MF; Abdou MM; Matsuura K; Watanabe T; Tanaka Y
    Liver Int; 2014 Jul; 34(6):890-5. PubMed ID: 24102823
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic polymorphism in IL28B is associated with spontaneous clearance of hepatitis C virus genotype 4 infection in an Egyptian cohort.
    Kurbanov F; Abdel-Hamid M; Latanich R; Astemborski J; Mohamed M; Mikhail NM; El-Daly M; El-Kafrawy S; Thomas DL; Thio CL
    J Infect Dis; 2011 Nov; 204(9):1391-4. PubMed ID: 21933876
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lack of Association Between Interleukin 28B Polymorphism and Vertical Transmission of Hepatitis C.
    Psaros Einberg A; Duberg AS; Filipovich O; Nyström J; Zhirkov A; Brenndörfer ED; Frelin L; Rukoiatkina E; Lobzin Y; Sällberg M; Fischler B; Lutckii A
    J Pediatr Gastroenterol Nutr; 2017 Dec; 65(6):608-612. PubMed ID: 28820758
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study.
    Rauch A; Kutalik Z; Descombes P; Cai T; Di Iulio J; Mueller T; Bochud M; Battegay M; Bernasconi E; Borovicka J; Colombo S; Cerny A; Dufour JF; Furrer H; Günthard HF; Heim M; Hirschel B; Malinverni R; Moradpour D; Müllhaupt B; Witteck A; Beckmann JS; Berg T; Bergmann S; Negro F; Telenti A; Bochud PY; ;
    Gastroenterology; 2010 Apr; 138(4):1338-45, 1345.e1-7. PubMed ID: 20060832
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Study of Interleukin 28B rs12979860 and rs8099917 Polymorphisms and T-helper 1 Response in Hepatitis C Virus Patients.
    Ea R; Aa G; Ag ES; Ma A
    Egypt J Immunol; 2015 Jun; 22(2):57-68. PubMed ID: 28502145
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Strong HCV NS3/4a, NS4b, NS5a, NS5b-specific cellular immune responses induced in Rhesus macaques by a novel HCV genotype 1a/1b consensus DNA vaccine.
    Latimer B; Toporovski R; Yan J; Pankhong P; Morrow MP; Khan AS; Sardesai NY; Welles SL; Jacobson JM; Weiner DB; Kutzler MA
    Hum Vaccin Immunother; 2014; 10(8):2357-65. PubMed ID: 25424943
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High resolution melting curve assay for detecting rs12979860 IL28B polymorphisms involved in response of Iranian patients to chronic hepatitis C treatment.
    Fateh A; Aghasadeghi MR; Keyvani H; Mollaie HR; Yari S; Hadizade Tasbiti AR; Ghazanfari M; Monavari SH
    Asian Pac J Cancer Prev; 2015; 16(5):1873-80. PubMed ID: 25773839
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interleukin-28b CC genotype predicts early treatment response and CT/TT genotypes predicts non-response in patients infected with HCV genotype 3.
    Gupta AC; Trehanpati N; Sukriti S; Hissar S; Midha V; Sood A; Sarin SK
    J Med Virol; 2014 Apr; 86(4):707-12. PubMed ID: 24415442
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distribution of IL28B and IL10 polymorphisms as genetic predictors of treatment response in Pakistani HCV genotype 3 patients.
    Naeemi H; Aslam R; Raza SM; Shahzad MA; Naz S; Manzoor S; Khaliq S
    Arch Virol; 2018 Apr; 163(4):997-1008. PubMed ID: 29340806
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.